相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clarifying the diagnosis of post-inflammatory pulmonary fibrosis: a population-based study
Ann Vu et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives
Teng Moua et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2019)
Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials
Lisa Lancaster et al.
BMJ OPEN RESPIRATORY RESEARCH (2019)
Balancing Covariates via Propensity Score Weighting
Fan Li et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2018)
Impact of Lung Function Decline on Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis (IPF)
M. Kreuter et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
Kevin R. Flaherty et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery
Xiaoxi Yao et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Physiology of the lung in idiopathic pulmonary fibrosis
Laurent Plantier et al.
EUROPEAN RESPIRATORY REVIEW (2018)
Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis Results of the INJOURNEY Trial
Carlo Vancheri et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
Helen E. Jo et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Pirfenidone and mortality in idiopathic pulmonary fibrosis
Paolo Spagnolo
LANCET RESPIRATORY MEDICINE (2017)
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis
Steven D. Nathan et al.
LANCET RESPIRATORY MEDICINE (2017)
Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS
Ulrich Costabel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Drug Treatment of Idiopathic Pulmonary Fibrosis Systematic Review and Network Meta-Analysis
William J. Canestaro et al.
CHEST (2016)
Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old
Ganesh Raghu et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Paola Rogliani et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2016)
Successful Concomitant Therapy with Pirfenidone and Nintedanib in Idiopathic Pulmonary Fibrosis: A Case Report
Lars Hagmeyer et al.
RESPIRATION (2016)
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
Luca Richeldi et al.
RESPIRATORY MEDICINE (2016)
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis An Update of the 2011 Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Comparing new treatments for idiopathic pulmonary fibrosis - a network meta-analysis
Emma Loveman et al.
BMC PULMONARY MEDICINE (2015)
Health Care Utilization and Costs of Idiopathic Pulmonary Fibrosis in US Medicare Beneficiaries Aged 65 Years and Older
Harold R. Collard et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
All-Cause Mortality Rate in Patients with Idiopathic Pulmonary Fibrosis Implications for the Design and Execution of Clinical Trials
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Optum Labs: Building A Novel Node In The Learning Health Care System
Paul J. Wallace et al.
HEALTH AFFAIRS (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A New Hope for Idiopathic Pulmonary Fibrosis
Gary M. Hunninghake
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Vascular remodelling in the pathogenesis of idiopathic pulmonary fibrosis
S. Barratt et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2014)
Combination therapy: the future of management for idiopathic pulmonary fibrosis?
Wim A. Wuyts et al.
LANCET RESPIRATORY MEDICINE (2014)
Selection of Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials in Idiopathic Pulmonary Fibrosis
Williamson Z. Bradford et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan A Parallel, Randomized Trial
Ganesh Raghu et al.
ANNALS OF INTERNAL MEDICINE (2013)
Consequences for Healthcare Quality and Research of the Exclusion of Records From the Death Master File
Briget da Graca et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2013)
Idiopathic Pulmonary Fibrosis Lung Function Is a Clinically Meaningful Endpoint for Phase III Trials
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Idiopathic Pulmonary Fibrosis: Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis
Imre Noth et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Propensity score applied to survival data analysis through proportional hazards models: a Monte Carlo study
Etienne Gayat et al.
PHARMACEUTICAL STATISTICS (2012)
Hot off the breath: Mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good
Athol U. Wells et al.
THORAX (2012)
Burden of illness in idiopathic pulmonary fibrosis
Harold R. Collard et al.
JOURNAL OF MEDICAL ECONOMICS (2012)
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
J. W. Song et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
Peter C. Austin
PHARMACEUTICAL STATISTICS (2011)
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
Peter C. Austin
STATISTICS IN MEDICINE (2009)
Incidence and prevalence of idiopathic pulmonary fibrosis
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
分享论文
